Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses

Clinical trial NCT05114707 · UNKNOWN

Trial details

NCT number: NCT05114707
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasal Cavity Cancer Paranasal Sinus Cancer Camrelizumab Induction Chemotherapy Intensity Modulated Radiotherapy Concurrent Chemotherapy

Start date: 2021-04-16
Primary completion: 2024-04-16
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.